Vectibix 100 mg/5 ml
Vectibix 100 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 57872. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 October 2008 and the authorisation is valid without a time limit. ATC code L01FE02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 57872 |
|---|---|
| Name | Vectibix 100 mg/5 ml |
| Full name | Vectibix 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Amgen Switzerland AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FE02 |
| First authorisation | 14 October 2008 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Vectibix 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 14 October 2008 |
| 3 | Vectibix 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 14 October 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FE02 | 07.16.1. | A |
| 3 | 1 | Durchstechflasche(n) | L01FE02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Vectibix 100 mg/5 ml authorised in Switzerland?
Yes. Vectibix 100 mg/5 ml is authorised by Swissmedic under authorisation number 57872, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Vectibix 100 mg/5 ml have?
Vectibix 100 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Vectibix 100 mg/5 ml?
The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.